Skip to main content
. 2021 Sep 3;35(5):2821–2829. doi: 10.21873/invivo.12569

Figure 4. Cycles of treatment completed before discontinuation for the four treatment groups. GC-f: Full-dose gemcitabine plus cisplatin (n=33); GC-r: reduced-dose gemcitabine plus cisplatin (n=10); G-Car-f: full-dose gemcitabine plus carboplatin (n=24); G-Car-r: reduced-dose gemcitabine plus carboplatin (n=11); AE: adverse event; CR: complete response; PD: progressive disease.

Figure 4